Merit Medical Systems (MMSI) Stock Price, News & Analysis

Company Overview

Merit Medical Systems, Inc. is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach. Headquartered in South Jordan, Utah, the company operates manufacturing and distribution facilities in North America, Europe and Asia. Merit’s products are sold in over 90 countries worldwide, with regional sales offices in Europe, Latin America and the Asia‐Pacific region to support local clinical training and customer service.

Under the leadership of founder and CEO Fred Lampropoulos, Merit Medical Systems has maintained a focus on innovation, quality and customer education. The company invests in research and development to evolve its product pipeline and partners with healthcare professionals to improve procedural outcomes. Merit’s commitment to minimally invasive care and patient safety has positioned it as a key supplier to hospitals and health systems seeking advanced device solutions for complex diagnostic and therapeutic procedures.

Key Stats

• Today's Range: $82.77 to $87.83
• 50-Day Range: $60.65 to $85.01
• 52-Week Range: $59.74 to $94.75
• Volume: 2.20 million shs
• Average Volume: 760,694 shs
• Market Capitalization: $5.07 billion
• P/E Ratio: 35.13
• Dividend Yield: N/A
• Price Target: $100.30
• Consensus Rating: Moderate Buy

Merit Medical Systems Stock Analysis - MarketRank™

Merit Medical Systems scored higher than 84% of companies evaluated by MarketBeat, and ranked 290th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Merit Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

Merit Medical Systems has a consensus price target of $100.30, representing about 18.0% upside from its current price of $85.01.

Amount of Analyst Coverage

Merit Medical Systems has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.84%

Earnings Growth

Earnings for Merit Medical Systems are expected to grow by 8.84% in the coming year, from $3.62 to $3.94 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Merit Medical Systems is 35.13, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.93.

Price to Earnings Ratio vs. Sector

The P/E ratio of Merit Medical Systems is 35.13, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 280.88.

Price to Earnings Growth Ratio

Merit Medical Systems has a PEG Ratio of 2.59. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Merit Medical Systems has a P/B Ratio of 3.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.81% of the float of Merit Medical Systems has been sold short.

Short Interest Ratio / Days to Cover

Merit Medical Systems has a short interest ratio ("days to cover") of 5.24.

Change versus previous month

Short interest in Merit Medical Systems has recently increased by 1.42%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Merit Medical Systems does not currently pay a dividend.

Dividend Growth

Merit Medical Systems does not have a long track record of dividend growth.

News and Social Media

• Score: 4.5 / 5
• News Sentiment: 1.24

News Sentiment

Merit Medical Systems has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 31 news articles for Merit Medical Systems this week, compared to 5 articles on an average week.

Search Interest

3 people have searched for MMSI on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

MarketBeat Follows

1 people have added Merit Medical Systems to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Merit Medical Systems insiders have sold 149.96% more of their company's stock than they have bought. Specifically, they have bought $125,240.00 in company stock and sold $313,050.00 in company stock.

Percentage Held by Insiders

0.70% of the stock of Merit Medical Systems is held by insiders.

Percentage Held by Institutions

99.66% of the stock of Merit Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/30/2026
• Today: 7/31/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:MMSI
• CIK: 856982
• Web: www.merit.com
• Phone: (801) 253-1600
• Fax: 801-253-1652
• Employees: 7,500
• Year Founded: 1987

Price Target and Rating

• Average Price Target for Merit Medical Systems: $100.30
• High Price Target: $114.00
• Low Price Target: $83.00
• Potential Upside/Downside: +18.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.64
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.31
• Trailing P/E Ratio: 35.13
• Forward P/E Ratio: 23.48
• P/E Growth: 2.59
• Net Income: $128.49 million
• Net Margins: 9.22%
• Pretax Margin: 12.09%
• Return on Equity: 13.97%
• Return on Assets: 8.24%

Debt

• Debt-to-Equity Ratio: 0.45
• Current Ratio: 5.08
• Quick Ratio: 3.46

Sales & Book Value

• Annual Sales: $1.52 billion
• Price / Sales: 3.35
• Cash Flow: $6.00 per share
• Price / Cash Flow: 14.18
• Book Value: $26.72 per share
• Price / Book: 3.18

Miscellaneous

• Outstanding Shares: 59,650,000
• Free Float: 59,237,000
• Market Cap: $5.07 billion
• Optionable: Optionable
• Beta: 0.52